These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32070160)

  • 21. Sodium Channels in Pain and Cancer: New Therapeutic Opportunities.
    Luiz AP; Wood JN
    Adv Pharmacol; 2016; 75():153-78. PubMed ID: 26920012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Discovery of voltage-gated sodium-channel blockers for the treatment of neuropathic pain].
    Watanabe S
    Nihon Yakurigaku Zasshi; 2012 Nov; 140(5):201-5. PubMed ID: 23138316
    [No Abstract]   [Full Text] [Related]  

  • 23. Sodium channel blockers for the treatment of neuropathic pain.
    Bhattacharya A; Wickenden AD; Chaplan SR
    Neurotherapeutics; 2009 Oct; 6(4):663-78. PubMed ID: 19789071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Na
    McKerrall SJ; Sutherlin DP
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state.
    Suter MR; Kirschmann G; Laedermann CJ; Abriel H; Decosterd I
    Anesthesiology; 2013 Jan; 118(1):160-72. PubMed ID: 23221868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging therapies for neuropathic pain: new molecules or new indications for old treatments?
    Bouhassira D; Attal N
    Pain; 2018 Mar; 159(3):576-582. PubMed ID: 29447137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
    Cummins TR; Rush AM
    Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
    Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
    Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management?
    Thomas AM; Atkinson TJ
    J Pain; 2018 Jan; 19(1):1-9. PubMed ID: 28842369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery and optimization of benzimidazoles as selective Na
    Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
    Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
    Sun S; Cohen CJ; Dehnhardt CM
    Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
    Payandeh J; Hackos DH
    Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in sodium channelopathies and biological functions of voltage-gated sodium channel blockers].
    Wang H; Gou M; Xiao R; Li Q
    Sheng Wu Gong Cheng Xue Bao; 2014 Jun; 30(6):875-90. PubMed ID: 25212005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New investigational drugs for the treatment of neuropathic pain.
    Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3'-Methoxydaidzein exerts analgesic activity by inhibiting voltage-gated sodium channels.
    Xu RJ; Fei SH; Chen LY; Wang G; Liu M; Zhang WS; Yan XW; Lai R; Shen CB
    Chin J Nat Med; 2019 Jun; 17(6):413-423. PubMed ID: 31262454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of lacosamide in the treatment of neuropathic pain].
    Bermejo PE; Alba-Alcantara L
    Rev Neurol; 2013 Feb; 56(3):188-90. PubMed ID: 23359081
    [No Abstract]   [Full Text] [Related]  

  • 38. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a novel series of pyridone amides as Na
    Wang Y; Hu S; Chen Y; Chen M; Zhang D; Liu W; Chen C; Gan Y; Luo M; Ke B
    Bioorg Med Chem Lett; 2024 Mar; 101():129655. PubMed ID: 38350529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause?
    Le Franc A; Da Silva A; Lepetre-Mouelhi S
    Drug Deliv Transl Res; 2024 Aug; 14(8):2112-2145. PubMed ID: 38861139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.